Biological
EVARREST® Fibrin Sealant Patch
EVARREST® Fibrin Sealant Patch is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_3
3
75%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 33 (75.0%)
Phase 41 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
NCT03255174
completedphase_4
EVARREST™ Fibrin Sealant Patch Post-Market Study
NCT01902459
completedphase_3
The Fibrin Pad CV Phase III Study
NCT02040428
completedphase_3
The EVARREST® Fibrin Sealant Patch Liver Study
NCT01993888
Clinical Trials (4)
Showing 4 of 4 trials
NCT03255174Phase 3
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
NCT01902459Phase 4
EVARREST™ Fibrin Sealant Patch Post-Market Study
NCT02040428Phase 3
The Fibrin Pad CV Phase III Study
NCT01993888Phase 3
The EVARREST® Fibrin Sealant Patch Liver Study
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4